en · de · es · pt
lab-handbook.peptides6908.com › Data › Background And Regulatory History — Practical Notes

Background And Regulatory History — Practical Notes

By Editorial Desk · published 2026-06-04 · last reviewed 2026-06-22 · Data

regulatory status is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-06-22. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Regulatory History

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

Identity and Pharmacological Mechanism

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Cardarine at a glance

PropertyValueNotes
Common nameCardarineCommon internet and media name.
Research codeGW501516Also written GW-1516.
Drug classPPARδ agonistNot a selective androgen receptor modulator.
Development statusDiscontinuedClinical development halted after rodent cancer findings.
Regulatory statusProhibited in sportListed by WADA; not approved as medicine.

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Related pages on this site

Regulatory Status and Detection Context

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

Supporting material

==== Eliminated in primary ==== Jarvis Johnson, former state representative from the 139th district (2016–2025), candidate for this district in 2010, candidate for Texas's 15th Senate district in the 2024 special and regular elections, and candidate for the 18th district in 2024 Robert Slater, business owner and candidate for the 18th district in 2024 and 2025

=== Islam === Consumption of food containing blood is forbidden by Islamic dietary laws. This is derived from the statement in the Qur'an, sura Al-Ma'ida (5:3): "Forbidden to you (for food) are: dead meat, blood, the flesh of swine, and that on which has been invoked the name of other than Allah." Blood is considered unclean, hence there are specific methods to obtain physical and ritual status of cleanliness once bleeding has occurred. Specific rules and prohibitions apply to menstruation, postnatal bleeding and irregular vaginal bleeding. When an animal has been slaughtered, the animal's neck is cut in a way to ensure that the spine is not severed, hence the brain may send commands to the heart to pump blood to it for oxygen. In this way, blood is removed from the body, and the meat is generally now safe to cook and eat. In modern times, blood transfusions are generally not considered against the rules.

DIPG is a terminal illness, since it has a 5-year survival rate of <1%. The median overall survival of children diagnosed with DIPG is approximately 9 months. The 1- and 2-year survival rates are approximately 30% and less than 10%, respectively. These statistics make DIPG one of the most devastating pediatric cancers. Although 75–85% of patients show some improvement in their symptoms after radiation therapy, DIPGs almost always begin to grow again (called recurrence, relapse, or progression). Clinical trials have reported that the median time between radiation therapy and progression is 5–8.8 months. Patients whose tumors begin to grow again may be eligible for experimental treatment through clinical trials to try to slow or stop the growth of the tumor. However, clinical trials have not shown any significant benefit from experimental DIPG therapies so far. For DIPGs that progress, they usually grow quickly and affect important parts of the brain. The median time from tumor progression to death is usually very short, between 1 and 4.5 months. During this time, doctors focus on palliative care: controlling symptoms and making the patient as comfortable as possible.

During February 1945, the 4th Panzer Army defended along the Oder River, containing the Soviet bridgehead at Steinau on the Oder. In March and the first half of April 1945, the army concentrated on defenses along the Lusatian Neisse River between Görlitz and Guben. On April 16, 1945, the Red Army renewed its offensive by crossing the Oder River. While the 9th Army held the Soviet forces at the Battle of Seelow Heights, the 4th Panzer Army was being pushed back. V Corps of the retreating 4th Panzer Army was pushed into the operational region of the German 9th Army, forming a pocket of some 80,000 men. The Red Army then encircled this force in a pocket in the Spree Forest south of the Seelow Heights and west of Frankfurt. Some of the 4th Panzer Army troops trapped in the Halbe Pocket broke out to the west and surrendered to the US Army on the west bank of the Elbe River. The bulk of the 4th Panzer Army was pushed south of Dresden into the Ore Mountains where it surrendered to the Red Army in the wake of the early May 1945 Prague Offensive.

In a meta analysis looking at many different phytochemical effects on prostate cancer, two specific studies using mice observed [6]-gingerol compounds induced apoptosis in cancer cells by interfering with the mitochondrial membrane. There were also observed mechanisms associated with the disruption of G1 phase proteins to stop the reproduction of cancer cells which is also an associated benefit of other relevant anticancer studies. The main mechanism by which gingerol phytochemicals act on cancer cells seems to be protein disruption. The anti-carcinogenic activity of [6]-gingerol and [6]-paradol was analysed in a study observing the cellular mechanisms associated with mouse skin cancer which targeted the activator proteins associated with tumor initiation. Gingerol compounds inhibited the transformation of normal cells into cancer cells by blocking AP-1 proteins and when cancer did develop paradol encouraged apoptosis due to its cytotoxic activity. [6]-Gingerol exhibits cell cycle arrest capabilities, apoptotic action and enzyme-coupled cell signaling receptor degradation in cancer cells. Gingerol has been observed to stop proliferation through inhibiting the translation of Cyclin proteins necessary for replication during G1 and G2 phase of cell division. To promote apoptosis in cancer cells Cytochrome C is ejected from the mitochondria which ceases ATP production leaving a dysfunctional mitochondria.

Sources: en.wikipedia.org

Notes from published material

==== Interfaith efforts ==== Curiosity about Islam increased after the attacks. As a result, many mosques and Islamic centers began holding open houses and participating in outreach efforts to educate non-Muslims about the faith. In the first 10 years after the attacks, interfaith community service increased from 8 to 20 percent, and the percentage of U.S. congregations involved in interfaith worship doubled from 7 to 14 percent.

== E == EBIC – Electron beam induced current (see IBIC: ion beam induced charge) EBS – Elastic (non-Rutherford) backscattering spectrometry (see RBS) EBSD – Electron backscatter diffraction ECOSY – Exclusive correlation spectroscopy ECT – Electrical capacitance tomography EDAX – Energy-dispersive analysis of x-rays EDMR – Electrically detected magnetic resonance, see ESR or EPR EDS or EDX – Energy dispersive X-ray spectroscopy EELS – Electron energy loss spectroscopy EFTEM – Energy filtered transmission electron microscopy EID – Electron induced desorption EIT and ERT – Electrical impedance tomography and electrical resistivity tomography EL – Electroluminescence Electron crystallography ELS – Electrophoretic light scattering ENDOR – Electron nuclear double resonance, see ESR or EPR EPMA – Electron probe microanalysis EPR – Electron paramagnetic resonance spectroscopy ERD or ERDA – Elastic recoil detection or elastic recoil detection analysis ESCA – Electron spectroscopy for chemical analysis see XPS ESD – Electron stimulated desorption ESEM – Environmental scanning electron microscopy ESI-MS or ES-MS – Electrospray ionization mass spectrometry or electrospray mass spectrometry ESR – Electron spin resonance spectroscopy ESTM – Electrochemical scanning tunneling microscopy EXAFS – Extended X-ray absorption fine structure EXSY – Exchange spectroscopy

== End-of-use == Plastic: Landfilling, burning, and recycling are all alternatives for plastic packaging at the end of their shelf-life. However, improper disposal and handling lead to higher percentages of plastic waste, which can pollute the environment in a wide spectrum of scenarios. The packaging sector accounts for 40.5% of all plastic produced in Europe, which represents the largest sector in food industry. However, the recycling of such wastege is at a critical low level of roughly 35%. Moreover, it has been estimated that over 20% of the plastic packaging does not reach any recycling process. Bioplastic: also known as biodegradable polymer or biopolymer, are usually made from renewable feedstock resources like corn, potatoes, wood pulp and sugarcane, as well as from renewable natural resources of different kind. Typical end-of-life options include the composting or the environmental degradation of bioplastics, which result in resource loss and CO2 production. Complete degradation is also only achievable under rigorous conditions that are infrequently offered by the company. Additionally, some bioplastics are processed similarly to their traditional, fossil-based counterparts, which, if improperly sorted, might cause harmful interferences in other materials' recycling processes. Paper, paperboard, and corrugated board: are composed of cellulosic fibers bonded together to form a flexible structure.

Since its 1947 independence, India has significantly reduced historically endemic diseases, though some remain intractable. The country was certified smallpox-free in April 1977 following two years of surveillance after its last Variola major case. It was officially certified polio-free by the World Health Organisation on 27 March 2014, after successfully completing three consecutive years without recorded cases of wild poliovirus. In contrast, cholera remains endemic to Ganges-Meghna Delta estuaries, resulting in seasonal outbreaks caused by monsoons and water supply network shortcomings. Tuberculosis is a major concern; India bears a quarter of the global tuberculosis disease burden. Historical malaria cases have dropped from millions to hundreds of thousands annually, but India experiences localised seasonal increases caused by drug-resistant variants of the Plasmodium falciparum and Plasmodium vivax vectors. Patients in India often face a stark choice: use basic, free, publicly funded health care or pay high out-of-pocket fees for better-equipped care from private doctors and hospitals. This divide is particularly severe outside cities, as public clinics in rural areas rarely have enough doctors or nurses to meet local demands. When serious medical emergencies occur, poorer families are often forced to sell land or take out high-interest loans to pay for private care. This resulting medical debt pushes approximately 55 million people into poverty every year.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Why did clinical development stop?

Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.

Is cardarine approved for medical use?

No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.

Network